Company Valuation: ResMed, Inc.

Fiscal Period: June 2020 2021 2022 2023 2024 2025 2026 2027
Capitalization 1 27,776 35,903 30,691 32,133 28,117 36,576 - -
Change - 29.26% -14.52% 4.7% -12.5% 30.09% - -
Enterprise Value (EV) 1 28,489 36,263 31,192 33,346 28,585 36,287 35,315 34,299
Change - 27.29% -13.98% 6.9% -14.28% 26.94% -2.68% -2.88%
P/E ratio 45x 76.1x 39.6x 35.9x 27.7x 28.4x 25.8x 23.9x
PBR 11.1x 12.4x 9.35x 7.76x - 6.25x 5.26x 4.35x
PEG - -3.2x 0.6x 2.4x 2x 1.1x 2.5x 3.01x
Capitalization / Revenue 9.39x 11.2x 8.58x 7.61x 6x 7.25x 6.78x 6.38x
EV / Revenue 9.63x 11.3x 8.72x 7.9x 6.1x 7.19x 6.54x 5.98x
EV / EBITDA 29.5x 33.8x 26.8x 25.3x 18.1x 20.3x 18.2x 16.6x
EV / EBIT 35.1x 40.1x 31.2x 27.2x 19.3x 21.6x 19.3x 17.6x
EV / FCF 40.3x 57.2x 144x 58.1x 22x 30.1x 24.1x 22.2x
FCF Yield 2.48% 1.75% 0.69% 1.72% 4.55% 3.32% 4.14% 4.51%
Dividend per Share 2 1.56 1.56 1.68 1.8 - 2.243 2.404 2.615
Rate of return 0.81% 0.63% 0.8% 0.82% - 0.9% 0.97% 1.05%
EPS 2 4.27 3.24 5.3 6.09 6.92 8.76 9.66 10.43
Distribution rate 36.5% 48.1% 31.7% 29.6% - 25.6% 24.9% 25.1%
Net sales 1 2,957 3,197 3,578 4,223 4,685 5,046 5,397 5,737
EBITDA 1 966 1,074 1,162 1,317 1,576 1,786 1,937 2,070
EBIT 1 811.2 903.7 1,000 1,224 1,478 1,680 1,831 1,953
Net income 1 621.7 474.5 779.4 897.6 1,021 1,297 1,433 1,562
Net Debt 1 713 360.1 501.5 1,213 468.9 -288.7 -1,261 -2,277
Reference price 2 192.00 246.52 209.63 218.50 191.42 248.93 248.93 248.93
Nbr of stocks (in thousands) 1,44,668 1,45,640 1,46,405 1,47,062 1,46,884 1,46,932 - -
Announcement Date 05/08/20 05/08/21 11/08/22 03/08/23 01/08/24 - - -
1USD in Million2USD
Estimates

P/E ratio, Detailed evolution

Add to a list
P/E ratio EV / Sales EV / EBITDA Yield (Y) Capi. ($)
28.42x7.19x20.32x+0.90%36.58B
37.98x6x23.88x+0.24%233B
47.32x8.88x27.63x+0.40%198B
85.6x20.9x51.42x-.--%174B
59.01x7.94x26.95x-.--%123B
27.81x3.01x15.13x+2.03%61.6B
29.42x6.43x20.89x-.--%41.28B
21.82x2.28x12.28x+0.13%39.69B
20.46x6.3x16.34x+2.98%39.49B
30.58x6.32x21.71x+0.68%39.45B
Average 38.84x 7.52x 23.65x +0.74% 98.64B
Weighted average by Cap. 47.88x 9.20x 28.22x +0.45%
See all sector valuations

Year-on-year evolution of the PER

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Equities
  3. RMD Stock
  4. Valuation ResMed, Inc.
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities. Last hours!
BENEFIT NOW